Table 4.
Compounds | Degree | Compounds | Betweenness |
---|---|---|---|
Hemorheological abnormality | |||
Quercetin | 32 | Quercetin | 0.0857877 |
Luteolin | 16 | Luteolin | 0.02594642 |
Isorhamnetin | 13 | Butylated hydroxytoluene∗ | 0.01562293 |
Butylated hydroxytoluene∗ | 12 | Isorhamnetin | 0.01488112 |
Isoliquiritigenin | 12 | Isoliquiritigenin∗ | 0.01377775 |
Nicotinic acid | 12 | Gallic acid | 0.01187844 |
Kaempferol | 12 | Berberine∗ | 0.01178984 |
Rosmarinic acid∗ | 11 | Nicotinic acid | 0.01170317 |
Campesterol | 11 | Glycyrrhizic acid∗ | 0.01089196 |
Berberine∗ | 10 | Rosmarinic acid∗ | 0.01077513 |
Coagulopathy | |||
Quercetin | 34 | Quercetin | 0.0827979 |
Isorhamnetin | 16 | Luteolin | 0.0211428 |
Luteolin | 14 | Wogonin | 0.0211385 |
Kaempferol | 14 | Isorhamnetin | 0.020552 |
Tangeretin∗ | 13 | Ellagic acid | 0.0161838 |
Berberine∗ | 13 | Tanshinone IIB | 0.0145945 |
Columbamine | 11 | Betaine | 0.0142141 |
Wogonin | 11 | Berberine∗ | 0.0130752 |
Z-ligustilide∗ | 10 | Ferulic acid∗ | 0.0130271 |
Ferulic acid∗ | 10 | Tangeretin∗ | 0.0124719 |
The active compounds which had been verified by UPLC-Q/TOF-MS in QXH were labeled with ∗.